Liraglutide and Semaglutide Business Analysis Report 2025: Market to Reach $29.8 Billion by 2030 - Growth in Off-Label Use for Weight Loss and Metabolic Syndrome …

Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to ...